Each order of AndroNorth BAM15 Tablets contains one (1) satchet of sixty (60) tablets, each containing 70mg of highly pure BAM15.
BAM15 is a synthetic small-molecule compound classified as a mitochondrial uncoupler, primarily studied for its potential role in regulating cellular energy metabolism and promoting metabolic health. It functions by selectively dissipating the proton gradient across the mitochondrial inner membrane, thereby reducing the efficiency of ATP production.
By uncoupling oxidative phosphorylation from ATP synthesis, BAM15 increases energy expenditure and stimulates the oxidation of fatty acids and glucose. This process leads to enhanced caloric utilization and reduced lipid accumulation, without significantly impairing essential cellular functions when used within controlled experimental parameters.
Unlike traditional mitochondrial uncouplers, BAM15 has been designed to demonstrate improved safety and tissue selectivity. Preclinical studies indicate that it does not significantly disrupt mitochondrial membrane potential in non-target tissues, nor does it markedly increase body temperature, distinguishing it from earlier compounds in this class.
In addition to its metabolic effects, BAM15 has shown potential benefits in reducing oxidative stress and improving mitochondrial efficiency. By modulating energy flux, it may help alleviate metabolic dysfunction associated with obesity, insulin resistance, and related disorders.
BAM15 is primarily used in research and experimental settings to investigate mitochondrial bioenergetics, metabolic regulation, and obesity-related pathways. Ongoing studies continue to explore its therapeutic potential and long-term safety profile in metabolic disease models.
Key Points
Action:
Acts as a mitochondrial uncoupler to increase energy expenditure by reducing ATP synthesis efficiency and enhancing substrate oxidation.
Indications:
Used in research related to obesity, metabolic disorders, insulin resistance, and mitochondrial function.
Difference from Other Uncouplers:
BAM15 is designed for improved selectivity and safety, showing reduced risk of hyperthermia and off-target toxicity compared to traditional mitochondrial uncoupling agents.
